111 related articles for article (PubMed ID: 5311472)
1. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
Ferreira EB; Eichemberg R; Berlitz MF
Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
[No Abstract] [Full Text] [Related]
2. [On the therapy of hypertension with an imidazoline derivative].
Krause W; Krämer D; Grünitz B
Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
[No Abstract] [Full Text] [Related]
3. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
Borrello G
Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
[No Abstract] [Full Text] [Related]
4. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
Langer-Costanzi M
Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
[No Abstract] [Full Text] [Related]
5. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
Corsini G; Di Filippo A; Cioffi A
Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
[No Abstract] [Full Text] [Related]
6. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
Ludwig H
Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
[No Abstract] [Full Text] [Related]
7. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
Vettore L
Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
[No Abstract] [Full Text] [Related]
8. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
Palagi L; D'Elia M; Lanzara P; Criscione SM
Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
[No Abstract] [Full Text] [Related]
9. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
Koch G
Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
[No Abstract] [Full Text] [Related]
10. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
Curri G
Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
[No Abstract] [Full Text] [Related]
11. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
Caparello O; Contino A; Viola A; Pirro G
Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
[No Abstract] [Full Text] [Related]
12. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
Fritsch H; Bachmann GW; Lenhard J
Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
[No Abstract] [Full Text] [Related]
13. [Treatment of arterial hypertension with ST-155].
Fonnesu C; Solinas F
Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
[No Abstract] [Full Text] [Related]
14. [Clinical experiences with a new antihypertensive agent].
Lieb W; Ridders K
Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
[No Abstract] [Full Text] [Related]
15. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
Seedat YK; Vawda EI; Mitha S; Ramasar R
S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
[No Abstract] [Full Text] [Related]
16. [Clinical experiences with the new antihypertensive agent Catapresan].
Messerich J
Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
[No Abstract] [Full Text] [Related]
17. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
Villalpando J; Skromme D; Chávez B; Serrano P
Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
[No Abstract] [Full Text] [Related]
18. Clonidine (Catapres): a new antihypertensive agent.
Khan A; Camel G; Perry HM
Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
[No Abstract] [Full Text] [Related]
19. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
Bergström J; Bergquist-Poppen M; Bucht H
Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
[No Abstract] [Full Text] [Related]
20. [Clinical and hemodynamic study of a new antihypertensive agent].
Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S
Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121
[No Abstract] [Full Text] [Related]
[Next] [New Search]